Related Experiment Video
Updated: Jul 6, 2026

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and
Chiara Carazzone1, Raffaella Colombo, Milena Quaglia
1Department of Pharmaceutical Chemistry, School of Pharmacy, University of Pavia, Pavia, Italy.
Abstract:
Human beta2-microglobulin (beta2-m) is a small amyloidogenic protein responsible for dialysis-related amyloidosis, which represents a severe complication of long-term hemodialysis. A therapeutic approach for this amyloidosis could be based on the stabilization of beta2-m through the binding to a small molecule, to possibly inhibit protein misfolding and amyloid fibril formation. The search of a strong ligand of this protein is extremely challenging: by using CE in affinity and refolding experiments we study the effect that previously selected sulfonated molecules have on the equilibrium between the native form and an ensemble of conformers populating the slow phase of beta2-m folding. These data are correlated with the effect that the same molecules exert on in vitro fibrillogenesis experiments.
Insights
Researchers investigated sulfonated molecules to stabilize human beta2-microglobulin (beta2-m), aiming to prevent dialysis-related amyloidosis. Findings suggest these molecules can influence beta2-m folding and inhibit amyloid formation.
Area of Science:
- Biochemistry
- Protein Misfolding Diseases
- Drug Discovery
Background:
- Dialysis-related amyloidosis is a severe complication of long-term hemodialysis, caused by the amyloidogenic protein beta2-microglobulin (beta2-m).
- Therapeutic strategies focus on stabilizing beta2-m to prevent protein misfolding and amyloid fibril formation.
Purpose of the Study:
- To investigate the effect of previously selected sulfonated molecules on the conformational equilibrium of human beta2-m.
- To assess the potential of these molecules as therapeutic agents for dialysis-related amyloidosis by evaluating their impact on beta2-m folding and in vitro fibrillogenesis.
Main Methods:
- Capillary electrophoresis (CE) was employed for affinity and refolding experiments to study beta2-m conformational changes.
- In vitro fibrillogenesis assays were conducted to evaluate the anti-amyloidogenic properties of the sulfonated molecules.
Main Results:
- The selected sulfonated molecules demonstrated an influence on the equilibrium between native beta2-m and its misfolded conformers.
- These molecules showed a correlation between their binding/refolding effects and their ability to inhibit in vitro beta2-m fibril formation.
Conclusions:
- Sulfonated molecules show promise in stabilizing beta2-m and inhibiting amyloid formation.
- These findings support the development of small molecule stabilizers as a therapeutic approach for dialysis-related amyloidosis.
More Related Videos
11:17Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021
18:27One-step Purification of Twin-Strep-tagged Proteins and Their Complexes on Strep-Tactin Resin Cross-linked With Bis(sulfosuccinimidyl) Suberate (BS3)
Published on: April 20, 2014
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme can...